Biomarkers of inflammation in asthma: A clinical perspective

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 6, 2012, Pages 620-629

  Taylor, D Robin ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

asthma; biomarkers; exhaled nitric oxide

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; CORTICOSTEROID; NITRIC OXIDE;

ACCURACY; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DISEASE CONTROL; DISEASE COURSE; DRUG RESPONSE; EOSINOPHIL; HUMAN; INFLAMMATION; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING TEST; SPUTUM ANALYSIS;

ASTHMA; BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; NITRIC OXIDE; PHENOTYPE; RESPIRATORY FUNCTION TESTS; SPIROMETRY; SPUTUM;

EID: 84867060673     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1326960     Document Type: Review

References (68)

1. Wenzel S. E. Asthma: defining of the persistent adult phenotypes. Lancet: 2006; 368 9537 804 813 (Pubitemid 44279058)
2. Taylor D. R., Bateman E. D., Boulet L. P., et al. A new perspective on concepts of asthma severity and control. Eur Respir J: 2008; 32 3 545 554
3. Diamant Z., Boot J. D., Mantzouranis E., Flohr R., Sterk P. J., Gerth van Wijk R. Biomarkers in asthma and allergic rhinitis. Pulm Pharmacol Ther: 2010; 23 6 468 481
4. Vijverberg S. J., Koenderman L., Koster E. S., van der Ent C. K., Raaijmakers J. A., Maitland-van der Zee A. H. Biomarkers of therapy responsiveness in asthma: pitfalls and promises. Clin Exp Allergy: 2011; 41 5 615 629
5. Maisel A., Mueller C., Adams K. Jr., et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail: 2008; 10 9 824 839
6. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax: 2003; 58 6 470 483
7. Kowal K., Bodzenta-Lukaszyk A., Zukowski S. Exhaled nitric oxide in evaluation of young adults with chronic cough. J Asthma: 2009; 46 7 692 698
8. Fabbri L. M., Romagnoli M., Corbetta L., et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med: 2003; 167 3 418 424 (Pubitemid 36216426)
9. Contoli M., Baraldo S., Marku B., et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol: 2010; 125 4 830 837
10. Chanez P., Vignola A. M., O'Shaugnessy T., et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med: 1997; 155 5 1529 1534 (Pubitemid 27216654)
11. Pavord I. D., Shaw D. E., Gibson P. G., Taylor D. R. Inflammometry to assess airway diseases. Lancet: 2008; 372 9643 1017 1019
12. Dragonieri S., Schot R., Mertens B. J., et al. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol: 2007; 120 4 856 862 (Pubitemid 47542280)
13. Montuschi P., Santonico M., Mondino C., et al. Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. Chest: 2010; 137 4 790 796
14. Bateman E. D., Boushey H. A., Bousquet J., et al. GOAL Investigators Group Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med: 2004; 170 8 836 844 (Pubitemid 39346477)
15. Brown H. M. Treatment of chronic asthma with prednisolone; significance of eosinophils in the sputum. Lancet: 1958; 2 7059 1245 1247
16. Bacci E., Cianchetti S., Bartoli M., et al. Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. Chest: 2006; 129 3 565 572
17. Berry M., Morgan A., Shaw D. E., et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax: 2007; 62 12 1043 1049 (Pubitemid 350206195)
18. Green R. H., Brightling C. E., Woltmann G., Parker D., Wardlaw A. J., Pavord I. D. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax: 2002; 57 10 875 879 (Pubitemid 35178612)
19. Pavord I. D., Brightling C. E., Woltmann G., Wardlaw A. J. Non-eosinophilic corticosteroid unresponsive asthma. Lancet: 1999; 353 9171 2213 2214 (Pubitemid 29295261)
20. Pizzichini E., Pizzichini M. M., Gibson P., et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med: 1998; 158 5 Pt 1 1511 1517
21. Leigh R., Pizzichini M. M., Morris M. M., Maltais F., Hargreave F. E., Pizzichini E. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J: 2006; 27 5 964 971 (Pubitemid 44911110)
22. Meijer R. J., Postma D. S., Kauffman H. F., Arends L. R., Koëter G. H., Kerstjens H. A. Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma. Clin Exp Allergy: 2002; 32 7 1096 1103 (Pubitemid 34779609)
23. Barnes P. J., Dweik R. A., Gelb A. F., et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest: 2010; 138 3 682 692
24. Schleich F. N., Seidel L., Sele J., et al. Exhaled nitric oxide thresholds associated with a sputum eosinophil count 3% in a cohort of unselected patients with asthma. Thorax: 2010; 65 12 1039 1044
25. Cowan D. C., Cowan J. O., Palmay R., Williamson A., Taylor D. R. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax: 2010; 65 5 384 390
26. Smith A. D., Cowan J. O., Brassett K. P., et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med: 2005; 172 4 453 459 (Pubitemid 41117391)
27. Dummer J. F., Epton M. J., Cowan J. O., et al. Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide. Am J Respir Crit Care Med: 2009; 180 9 846 852
28. Hahn P. Y., Morgenthaler T. Y., Lim K. G. Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough. Mayo Clin Proc: 2007; 82 11 1350 1355 (Pubitemid 350060130)
29. Cowan D. C., Cowan J. O., Palmay R., Williamson A., Taylor D. R. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax: 2010; 65 5 384 390
30. Haldar P., Pavord I. D., Shaw D. E., et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med: 2008; 178 3 218 224
31. Jatakanon A., Lim S., Barnes P. J. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med: 2000; 161 1 64 72 (Pubitemid 30055904)
32. Deykin A., Lazarus S. C., Fahy J. V., et al. Asthma Clinical Research Network, National Heart, Lung, and Blood Institute/NIH Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol: 2005; 115 4 720 727 (Pubitemid 40460845)
33. Jayaram L., Pizzichini M. M., Cook R. J., et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J: 2006; 27 3 483 494 (Pubitemid 43372521)
34. Green R. H., Brightling C. E., McKenna S., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet: 2002; 360 9347 1715 1721 (Pubitemid 35447900)
35. D'silva L., Gafni A., Thabane L., et al. Cost analysis of monitoring asthma treatment using sputum cell counts. Can Respir J: 2008; 15 7 370 374
36. Petsky H. L., Cates C. J., Lasserson T. J., et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax: 2012; 67 3 199 208
37. Gibson P. G. Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies. Clin Exp Allergy: 2009; 39 4 478 490
38. Smith A. D., Cowan J. O., Brassett K. P., Herbison G. P., Taylor D. R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med: 2005; 352 21 2163 2173
39. Powell H., Murphy V. E., Taylor D. R., et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind randomised controlled trial. Lancet: 2011; 378 9795 983 990
40. Pérez De Llano L. A., Carballada F., Castro Añón O., et al. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma. Eur Respir J: 2010; 35 6 1221 1227
41. Hashimoto S., Brinke A. T., Roldaan A. C., et al. Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial. Thorax: 2011; 66 6 514 520
42. Hewitt R. S., Modrich C. M., Cowan J. O., Herbison G. P., Taylor D. R. Outcomes using exhaled nitric oxide measurements as an adjunct to primary care asthma management. Prim Care Respir J: 2009; 18 4 320 327
43. Dweik R. A., Boggs P. B., Erzurum S. C., et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med: 2011; 184 5 602 615
44. van Veen I. H., Ten Brinke A., Sterk P. J., et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma. Eur Respir J: 2008; 32 2 344 349
45. Caudri D., Wijga A. H., Hoekstra M. O., et al. Prediction of asthma in symptomatic preschool children using exhaled nitric oxide, Rint and specific IgE. Thorax: 2010; 65 9 801 807
46. Dweik R. A., Sorkness R. L., Wenzel S., et al. National Heart, Lung, and Blood Institute Severe Asthma Research Program Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med: 2010; 181 10 1033 1041
47. Tossa P., Paris C., Zmirou-Navier D., et al. Increase in exhaled nitric oxide is associated with bronchial hyperresponsiveness among apprentices. Am J Respir Crit Care Med: 2010; 182 6 738 744
48. Prasad A., Langford B., Stradling J. R., Ho L. P. Exhaled nitric oxide as a screening tool for asthma in school children. Respir Med: 2006; 100 1 167 173 (Pubitemid 43033392)
49. Kostikas K., Papaioannou A. I., Tanou K., Koutsokera A., Papala M., Gourgoulianis K. I. Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season. Chest: 2008; 133 4 906 913 (Pubitemid 351536865)
50. Arora R., Thornblade C. E., Dauby P. A., Flanagan J. W., Bush A. C., Hagan L. L. Exhaled nitric oxide levels in military recruits with new onset asthma. Allergy Asthma Proc: 2006; 27 6 493 498 (Pubitemid 44916015)
51. Deykin A., Massaro A. F., Drazen J. M., Israel E. Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am J Respir Crit Care Med: 2002; 165 12 1597 1601 (Pubitemid 34693938)
52. Malmberg L. P., Pelkonen A. S., Haahtela T., Turpeinen M. Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax: 2003; 58 6 494 499 (Pubitemid 36714010)
53. Smith A. D., Cowan J. O., Filsell S., et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med: 2004; 169 4 473 478 (Pubitemid 38187119)
54. Pedrosa M., Cancelliere N., Barranco P., López-Carrasco V., Quirce S. Usefulness of exhaled nitric oxide for diagnosing asthma. J Asthma: 2010; 47 7 817 821
55. Lex C., Dymek S., Heying R., Kovacevic A., Kramm C. M., Schuster A. Value of surrogate tests to predict exercise-induced bronchoconstriction in atopic childhood asthma. Pediatr Pulmonol: 2007; 42 3 225 230 (Pubitemid 46417694)
56. Baur X., Barbinova L. Latex allergen exposure increases exhaled nitric oxide in symptomatic healthcare workers. Eur Respir J: 2005; 25 2 309 316 (Pubitemid 40246532)
57. Ferrazzoni S., Scarpa M. C., Guarnieri G., Corradi M., Mutti A., Maestrelli P. Exhaled nitric oxide and breath condensate pH in asthmatic reactions induced by isocyanates. Chest: 2009; 136 1 155 162
58. Vahlkvist S., Sinding M., Skamstrup K., Bisgaard H. Daily home measurements of exhaled nitric oxide in asthmatic children during natural birch pollen exposure. J Allergy Clin Immunol: 2006; 117 6 1272 1276 (Pubitemid 43795757)
59. Hewitt R. S., Smith A. D., Cowan J. O., Schofield J. C., Herbison G. P., Taylor D. R. Serial exhaled nitric oxide measurements in the assessment of laboratory animal allergy. J Asthma: 2008; 45 2 101 107 (Pubitemid 351416960)
60. Berkman N., Avital A., Breuer R., Bardach E., Springer C., Godfrey S. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax: 2005; 60 5 383 388 (Pubitemid 40685820)
61. Little S. A., Chalmers G. W., MacLeod K. J., McSharry C., Thomson N. C. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax: 2000; 55 3 232 234 (Pubitemid 30245974)
62. McNicholl D. M., Stevenson M., McGarvey L., Heaney L. Developing and validating a FeNO suppression test identifying non-adherence in difficult asthma. Am J Respir Crit Care Med: 2011; 183 A4379
63. Pijnenburg M. W., Hofhuis W., Hop W. C., De Jongste J. C. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax: 2005; 60 3 215 218 (Pubitemid 40380280)
64. Zacharasiewicz A., Wilson N., Lex C., et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med: 2005; 171 10 1077 1082 (Pubitemid 40663717)
65. Jones S. L., Kittelson J., Cowan J. O., et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med: 2001; 164 5 738 743 (Pubitemid 32881906)
66. Gelb A. F., Flynn Taylor C., Shinar C. M., Gutierrez C., Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest: 2006; 129 6 1492 1499 (Pubitemid 43894977)
67. Michils A., Baldassarre S., Van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J: 2008; 31 3 539 546
68. Michils A., Louis R., Peché R., Baldassarre S., Van Muylem A. Exhaled nitric oxide as a marker of asthma control in smoking patients. Eur Respir J: 2009; 33 6 1295 1301